The global cancer vaccines market is projected to grow at a CAGR of 9.62% to reach US$9.896 billion by 2024, from US$5.704 billion in 2018. Cancer vaccines are either used to protect against cancer or provide treatment. Hence, they are categorized into two types namely prevention and treatment. The growing incidences of cancers worldwide are one of the major market drivers driving the growth of the global cancer vaccines market in the forecast period. Cancer Vaccines are approved for Hepatitis B (HBV) and Human Papilloma Virus (HPV) by FDA. The growing aging population globally may, however, hamper the market growth due to the weak immune system of the elderly population, there are chances where they may be unable to produce an immune response after vaccination.
This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical regions. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.
Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the global cancer vaccines value chain. The last step involves complete market engineering which includes analyzing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the global cancer vaccines market.
Major industry players profiled as part of the report are AstraZeneca, GlaxoSmithKline plc., Merck & Co., Inc., Pfizer Inc. and Sanofi among others.
The global cancer vaccines market has been analyzed through following segments:
Middle East and Africa